Detalhe da pesquisa
1.
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer.
Mod Pathol
; 31(6): 947-955, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29410488
2.
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancer.
J Biol Chem
; 290(12): 7345-59, 2015 Mar 20.
Artigo
Inglês
| MEDLINE | ID: mdl-25623065
3.
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.
Ann Diagn Pathol
; 18(3): 140-5, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24747001
4.
Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.
Cancer
; 118(9): 2454-65, 2012 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-21952750
5.
Epidermal growth factor receptor and K-Ras mutations and resistance of lung cancer to insulin-like growth factor 1 receptor tyrosine kinase inhibitors.
Cancer
; 118(16): 3993-4003, 2012 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22359227
6.
Assessing environmental and occupational risk factors for lung cancer in Mexican-Americans.
Cancer Causes Control
; 21(12): 2157-64, 2010 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-20809339
7.
Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer.
Clin Cancer Res
; 14(19): 6014-22, 2008 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18829480
8.
Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method.
Cancer Res
; 67(14): 6565-73, 2007 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17638865
9.
Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma.
Nat Commun
; 10(1): 2978, 2019 07 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31278276
10.
Survivin expression in normal human bronchial epithelial cells: an early and critical step in tumorigenesis induced by tobacco exposure.
Carcinogenesis
; 29(8): 1614-22, 2008 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-18635526
11.
Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
Int J Cancer
; 122(1): 5-14, 2008 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17764071
12.
Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advance.
Nat Clin Pract Oncol
; 5(11): 628-9, 2008 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-18725921
13.
Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib.
Clin Cancer Res
; 13(9): 2795-803, 2007 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17473213
14.
Identification and validation of differences in protein levels in normal, premalignant, and malignant lung cells and tissues using high-throughput Western Array and immunohistochemistry.
Cancer Res
; 66(23): 11194-206, 2006 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17145864
15.
Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib.
Cancer Res
; 66(20): 10100-11, 2006 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17047074
16.
Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion.
Mol Cancer Ther
; 6(7): 1962-72, 2007 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-17620427
17.
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.
J Thorac Oncol
; 13(2): 246-257, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29313814
18.
Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer.
J Natl Cancer Inst
; 110(3)2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29617836
19.
Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer.
Oncotarget
; 9(18): 14268-14284, 2018 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29581842
20.
Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer.
Oncotarget
; 9(74): 33995-34008, 2018 Sep 21.
Artigo
Inglês
| MEDLINE | ID: mdl-30338041